Literature DB >> 8406563

Identification and quantification of complement regulator CD46 on normal human tissues.

R W Johnstone1, B E Loveland, I F McKenzie.   

Abstract

CD46 is a cell-surface regulatory molecule that prevents lysis of autologous human cells by activated complement. It has been well characterized on leucocytes, reproductive cells and various cultured cell lines and is considered to be ubiquitously expressed. We now extend these analyses and describe CD46 in a variety of different human tissues. Strong expression was observed by immunohistology on epithelial cells lining exocrine ducts and glands, such as salivary gland and pancreas and on kidney tubules and glomerular epithelium. Quantitative tissue expression was measured by radioimmunoassay and confirmed histological observations. Thus, CD46 is highly expressed on cells in contact with extracellular fluids thought not to contain large quantities of complement but which may still be subjected to complement attack thereby necessitating the presence of complement regulators to prevent non-specific destruction of cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406563      PMCID: PMC1421998     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Functional characterisation of alternatively spliced CD46 cytoplasmic tails.

Authors:  S M Russell; B E Loveland; R W Johnstone; B R Thorley; I F McKenzie
Journal:  Transplant Proc       Date:  1992-10       Impact factor: 1.066

2.  Mechanism of action of the C3b inactivator: requirement for a high molecular weight cofactor (C3b-C4bINA cofactor) and production of a new C3b derivative (C3b').

Authors:  S Nagasawa; R M Stroud
Journal:  Immunochemistry       Date:  1977 Nov-Dec

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Hu Ly-m5: a unique antigen physically associated with HLA molecules.

Authors:  R L Sparrow; I F McKenzie
Journal:  Hum Immunol       Date:  1983-05       Impact factor: 2.850

5.  Use of immunocytochemical techniques in studying the biogenesis of cell surfaces in polarized epithelia.

Authors:  H Reggio; P Webster; D Louvard
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Monoclonal antibodies to the murine Ly-2.1 cell surface antigen.

Authors:  P M Hogarth; J Edwards; I F McKenzie; J W Goding; F Y Liew
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

7.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

8.  Modulation of the alternative complement pathways by beta 1 H globulin.

Authors:  K Whaley; S Ruddy
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

9.  Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.

Authors:  M E Medof; K Iida; C Mold; V Nussenzweig
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

10.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  24 in total

1.  Molecular characterization of complement components (C3, C4, and factor B) in human saliva.

Authors:  A Andoh; Y Fujiyama; T Kimura; H Uchihara; H Sakumoto; H Okabe; T Bamba
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

2.  Expression of human CD46 has no effect on porcine circovirus type 2 infection and shedding in the experimental pig model.

Authors:  Michelle Hemann; Hui-Gang Shen; Nathan M Beach; Xiang-Jin Meng; Patrick G Halbur; Tanja Opriessnig
Journal:  Vet Res Commun       Date:  2012-03-03       Impact factor: 2.459

3.  Engineering of recombinant soluble CD46: an inhibitor of complement activation.

Authors:  D Christiansen; J Milland; B R Thorley; I F McKenzie; P L Mottram; L J Purcell; B E Loveland
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

4.  Expression of complement regulating factors in gastric cancer cells.

Authors:  T Inoue; M Yamakawa; T Takahashi
Journal:  Mol Pathol       Date:  2002-06

Review 5.  CD46 processing: a means of expression.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Immunobiology       Date:  2011-07-13       Impact factor: 3.144

6.  Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.

Authors:  Miho Murakami; Hideyo Ugai; Natalya Belousova; Alexander Pereboev; Paul Dent; Paul B Fisher; Maaike Everts; David T Curiel
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

7.  Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.

Authors:  A Mäenpää; S Junnikkala; J Hakulinen; T Timonen; S Meri
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

8.  Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9.

Authors:  Joséphine M Reynaud; Jean-François Jégou; Jérémy C Welsch; Branka Horvat
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

9.  Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.

Authors:  Anna Richards; Elizabeth J Kemp; M Kathryn Liszewski; Judith A Goodship; Anne K Lampe; Ronny Decorte; M Hamza Müslümanoğlu; Salih Kavukcu; Guido Filler; Yves Pirson; Leana S Wen; John P Atkinson; Timothy H J Goodship
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

10.  Measles virus spread and pathogenesis in genetically modified mice.

Authors:  B Mrkic; J Pavlovic; T Rülicke; P Volpe; C J Buchholz; D Hourcade; J P Atkinson; A Aguzzi; R Cattaneo
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.